Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers

We began analyzing https://ccforum.biomedcentral.com/articles/10.1186/cc9233, but it redirected us to https://ccforum.biomedcentral.com/articles/10.1186/cc9233. The analysis below is for the second page.

Title[redir]:
Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes | Critical Care | Full Text
Description:
Introduction Gas6, the protein product of the growth arrest specific gene 6, is present in human circulation at subnanomolar concentrations. It is secreted by endothelial cells and is important for the activation of endothelium during inflammation. Axl, the tyrosine kinase receptor for Gas6, is also present in endothelium and can be cleaved and released into the circulation. The soluble of form Axl (sAxl), which is present in plasma, can bind Gas6 and inhibit Axl-mediated cell signalling. Methods We have developed reproducible and accurate enzyme-linked immunosorbent assays for both Gas6 and sAxl and used them to investigate plasma samples from 70 patients with severe sepsis, 99 patients with sepsis, 42 patients with various infections causing fever but no systemic inflammatory response syndrome (SIRS), 20 patients with SIRS without verified infection, and 100 blood donors that served as controls. Correlations between Gas6 and sAxl concentrations and other commonly used analytes were investigated. Results The patients with severe sepsis, sepsis, infection or SIRS had all increased concentrations of Gas6, approximately double compared to what was found in the controls. The concentrations of sAxl were also increased in the patient groups compared to the controls. Gas6 correlated with C-reactive protein, procalcitonin and interleukin 6, whereas sAxl correlated to bilirubin and procalcitonin. Conclusions We can confirm results of earlier studies showing that circulating Gas6 is increased in sepsis and related syndromes. sAxl is increased, but less pronounced than Gas6. The concentrations of Gas6 and sAxl correlate with a number of inflammatory markers, suggesting a role in systemic inflammation.

Matching Content Categories {📚}

  • News & Politics
  • Politics
  • Cryptocurrency

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 75,529,999 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

gas, saxl, sepsis, patients, article, concentrations, pubmed, plasma, sirs, increased, google, scholar, protein, cas, axl, severe, groups, failure, inflammatory, care, infection, blood, patient, study, organ, growth, response, number, cells, tyrosine, cell, table, authors, data, soluble, kinase, receptor, dahlbäck, controls, compared, procalcitonin, analysis, systemic, samples, infections, found, correlated, related, university, criteria,

Topics {✒️}

vitamin k-dependent ligands vitamin k-dependent protein pi3 kinase/akt pathway growth arrest-specific gene tyrosine kinase receptor critical care medicine full size image receptor tyrosine kinases authors scientific editing privacy choices/manage cookies tyrosine kinase receptors complex clinical syndrome article ekman bmc damaging host response innate immune response international consensus conference related inflammatory syndromes severe sepsis group swedish research council adam10-dependent cleavage severe inflammatory reactions inflammatory reactions suggests increased signaling occurs combined severe sepsis significance levels observed severe inflammatory states related inflammatory conditions authors’ original file acute phase protein systolic blood pressure blood coagulation cascade inflammatory response european economic area catching polyclonal antibody biotinylated secondary antibody standard curve prepared rank correlation coefficient garcia de frutos di santo jp hansa medical ab c-reactive protein experiencing kidney failure 50 mm tris-hcl biomed central gas6 induced signaling genes specifically expressed urinary tract infections upper respiratory infections author information authors

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes
         description:Gas6, the protein product of the growth arrest specific gene 6, is present in human circulation at subnanomolar concentrations. It is secreted by endothelial cells and is important for the activation of endothelium during inflammation. Axl, the tyrosine kinase receptor for Gas6, is also present in endothelium and can be cleaved and released into the circulation. The soluble of form Axl (sAxl), which is present in plasma, can bind Gas6 and inhibit Axl-mediated cell signalling. We have developed reproducible and accurate enzyme-linked immunosorbent assays for both Gas6 and sAxl and used them to investigate plasma samples from 70 patients with severe sepsis, 99 patients with sepsis, 42 patients with various infections causing fever but no systemic inflammatory response syndrome (SIRS), 20 patients with SIRS without verified infection, and 100 blood donors that served as controls. Correlations between Gas6 and sAxl concentrations and other commonly used analytes were investigated. The patients with severe sepsis, sepsis, infection or SIRS had all increased concentrations of Gas6, approximately double compared to what was found in the controls. The concentrations of sAxl were also increased in the patient groups compared to the controls. Gas6 correlated with C-reactive protein, procalcitonin and interleukin 6, whereas sAxl correlated to bilirubin and procalcitonin. We can confirm results of earlier studies showing that circulating Gas6 is increased in sepsis and related syndromes. sAxl is increased, but less pronounced than Gas6. The concentrations of Gas6 and sAxl correlate with a number of inflammatory markers, suggesting a role in systemic inflammation.
         datePublished:2010-08-23T00:00:00Z
         dateModified:2010-08-23T00:00:00Z
         pageStart:1
         pageEnd:5
         license:http://creativecommons.org/licenses/by/2.0/
         sameAs:https://doi.org/10.1186/cc9233
         keywords:
            Severe Sepsis
            Organ Failure
            Systemic Inflammatory Response Syndrome
            Procalcitonin
            Sepsis Group
            Intensive / Critical Care Medicine
            Emergency Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcc9233/MediaObjects/13054_2010_Article_8637_Fig1_HTML.jpg
         isPartOf:
            name:Critical Care
            issn:
               1364-8535
            volumeNumber:14
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Carl Ekman
               affiliation:
                     name:Lund University, Skåne University Hospital
                     address:
                        name:Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Adam Linder
               affiliation:
                     name:Lund University, Skåne University Hospital
                     address:
                        name:Department of Clinical Sciences, Division of Infection Medicine, Lund University, Skåne University Hospital, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Per Åkesson
               affiliation:
                     name:Lund University, Skåne University Hospital
                     address:
                        name:Department of Clinical Sciences, Division of Infection Medicine, Lund University, Skåne University Hospital, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Björn Dahlbäck
               affiliation:
                     name:Lund University, Skåne University Hospital
                     address:
                        name:Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes
      description:Gas6, the protein product of the growth arrest specific gene 6, is present in human circulation at subnanomolar concentrations. It is secreted by endothelial cells and is important for the activation of endothelium during inflammation. Axl, the tyrosine kinase receptor for Gas6, is also present in endothelium and can be cleaved and released into the circulation. The soluble of form Axl (sAxl), which is present in plasma, can bind Gas6 and inhibit Axl-mediated cell signalling. We have developed reproducible and accurate enzyme-linked immunosorbent assays for both Gas6 and sAxl and used them to investigate plasma samples from 70 patients with severe sepsis, 99 patients with sepsis, 42 patients with various infections causing fever but no systemic inflammatory response syndrome (SIRS), 20 patients with SIRS without verified infection, and 100 blood donors that served as controls. Correlations between Gas6 and sAxl concentrations and other commonly used analytes were investigated. The patients with severe sepsis, sepsis, infection or SIRS had all increased concentrations of Gas6, approximately double compared to what was found in the controls. The concentrations of sAxl were also increased in the patient groups compared to the controls. Gas6 correlated with C-reactive protein, procalcitonin and interleukin 6, whereas sAxl correlated to bilirubin and procalcitonin. We can confirm results of earlier studies showing that circulating Gas6 is increased in sepsis and related syndromes. sAxl is increased, but less pronounced than Gas6. The concentrations of Gas6 and sAxl correlate with a number of inflammatory markers, suggesting a role in systemic inflammation.
      datePublished:2010-08-23T00:00:00Z
      dateModified:2010-08-23T00:00:00Z
      pageStart:1
      pageEnd:5
      license:http://creativecommons.org/licenses/by/2.0/
      sameAs:https://doi.org/10.1186/cc9233
      keywords:
         Severe Sepsis
         Organ Failure
         Systemic Inflammatory Response Syndrome
         Procalcitonin
         Sepsis Group
         Intensive / Critical Care Medicine
         Emergency Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcc9233/MediaObjects/13054_2010_Article_8637_Fig1_HTML.jpg
      isPartOf:
         name:Critical Care
         issn:
            1364-8535
         volumeNumber:14
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Carl Ekman
            affiliation:
                  name:Lund University, Skåne University Hospital
                  address:
                     name:Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Adam Linder
            affiliation:
                  name:Lund University, Skåne University Hospital
                  address:
                     name:Department of Clinical Sciences, Division of Infection Medicine, Lund University, Skåne University Hospital, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Per Åkesson
            affiliation:
                  name:Lund University, Skåne University Hospital
                  address:
                     name:Department of Clinical Sciences, Division of Infection Medicine, Lund University, Skåne University Hospital, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Björn Dahlbäck
            affiliation:
                  name:Lund University, Skåne University Hospital
                  address:
                     name:Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Critical Care
      issn:
         1364-8535
      volumeNumber:14
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Lund University, Skåne University Hospital
      address:
         name:Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden
         type:PostalAddress
      name:Lund University, Skåne University Hospital
      address:
         name:Department of Clinical Sciences, Division of Infection Medicine, Lund University, Skåne University Hospital, Lund, Sweden
         type:PostalAddress
      name:Lund University, Skåne University Hospital
      address:
         name:Department of Clinical Sciences, Division of Infection Medicine, Lund University, Skåne University Hospital, Lund, Sweden
         type:PostalAddress
      name:Lund University, Skåne University Hospital
      address:
         name:Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Carl Ekman
      affiliation:
            name:Lund University, Skåne University Hospital
            address:
               name:Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden
               type:PostalAddress
            type:Organization
      name:Adam Linder
      affiliation:
            name:Lund University, Skåne University Hospital
            address:
               name:Department of Clinical Sciences, Division of Infection Medicine, Lund University, Skåne University Hospital, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Per Åkesson
      affiliation:
            name:Lund University, Skåne University Hospital
            address:
               name:Department of Clinical Sciences, Division of Infection Medicine, Lund University, Skåne University Hospital, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Björn Dahlbäck
      affiliation:
            name:Lund University, Skåne University Hospital
            address:
               name:Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden
      name:Department of Clinical Sciences, Division of Infection Medicine, Lund University, Skåne University Hospital, Lund, Sweden
      name:Department of Clinical Sciences, Division of Infection Medicine, Lund University, Skåne University Hospital, Lund, Sweden
      name:Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden

External Links {🔗}(154)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
3.99s.